EXPERIENCE OF TREATMENT WITH LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE (RVD) IN THE FIRST LINE IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA IN THE HOSPITALS OF ARAGON AND THE PROVINCE OF SORIA

被引：0
|
作者：
Yus Cebrian, F. [1 ]
Paul Vidaller, P. J. [1 ]
Romero Quezada, L. L. [1 ]
Perella Arnal, M., I [1 ]
Campuzano Saavedra, V [2 ]
Sancho Val, L., I [3 ]
Gonzalez Gomez, N. [4 ]
Marco Amigot, J. J. [5 ]
Murillo Flores, I. M. [5 ]
Carrasco Baraja, V [6 ]
Godoy Molias, A. C. [7 ]
Paricio Moreno, M. [3 ]
Malo Yague, M. [8 ]
Delgado Beltran, M. P. [7 ]
Aguilar Franco, C. [2 ]
Palomera Bernal, L. R. [9 ]
机构：
[1] Hosp Barbastro, Huesca, Huesca, Spain
[2] Hosp Santa Barbara, Puertollano, Spain
[3] Hosp Alcaniz, Alcaniz, Teruel, Spain
[4] Hosp Obispo Polanco, Teruel, Spain
[5] Hosp San Jorge, Huesca, Spain
[6] Hosp Royo Villanova, Zaragoza, Spain
[7] Hosp Miguel Servet, Zaragoza, Spain
[8] Hosp Ernest Lluch, Zaragoza, Spain
[9] Hosp Clin Lozano Blesa, Zaragoza, Spain
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-013
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [1] Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
    Joseph, Nisha
    Almaula, Dhwani
    Gleason, Charise
    Heffner, Leonard
    Boise, Lawrence H.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay
    [J]. BLOOD, 2017, 130
  • [2] Our Experience of Using Lenalidomide, Bortezomib and Dexamethasone (RVD) Therapy in Patients with Relapsed/Refractory Multiple Myeloma
    Pogosyan, Gayane
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S340 - S341
  • [3] Incidence and risk factors for bacterial infection in newly diagnosed multiple myeloma patients undergoing treatment with bortezomib, lenalidomide, and dexamethasone (RVD).
    Pianko, Matthew James
    Bici, Anisa
    Nachar, Victoria
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Efficacy of Induction Thearapy with Lenalidomide, Bortezomib, and Dexamethasone (RVD) in 1000 Newly Diagnosed Multiple Myeloma (MM) Patients
    Joseph, Nisha
    Gupta, Vikas A.
    Hofmeister, Craig C.
    Gleason, Charise
    Heffner, Leonard
    Boise, Lawrence H.
    Kaufman, Jonathan L.
    Dhodapkar, Madhav V.
    Lonial, Sagar
    Nooka, Ajay K.
    [J]. BLOOD, 2018, 132
  • [5] Peripheral neuropathy in multiple myeloma patients receiving lenalidomide, bortezomib, and dexamethasone (RVD) therapy
    Voorhees, Peter M.
    Laubach, Jacob
    Anderson, Kenneth C.
    Richardson, Paul G.
    [J]. BLOOD, 2013, 121 (05) : 858 - 858
  • [6] BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (VRD) AS FIRST-LINE TREATMENT IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA. EXPERIENCE IN NON-CANDIDATE PATIENTS FOR HEMATOPOIETIC PROGENITOR TRANSPLANTATION
    Llorente Dunia, De Miguel
    Lopez Irene, Nuevo
    Munoz Beatriz, Merchan
    Argumanez Marta, Mora
    Perez Angela, Gil
    Ramo Alejandro, Vazquez
    Garcia Helga, Guillen
    Lopez Nuria, Golbano
    Ana Belen, Santos Montero
    Perez Dolores, Subira
    Juanis Jaime, Arbeteta
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 340 - 341
  • [7] Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
    Liang, Dong
    Bai, Shenrui
    Feng, Demei
    Chen, Guanjun
    Liang, Yang
    Wang, Hua
    [J]. BMC CANCER, 2024, 24 (01)
  • [8] Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma
    Bici, Anisa
    Pianko, Matthew J.
    Nachar, Victoria R.
    [J]. LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 407 - 414
  • [9] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION AS FIRST LINE TREATMENT IN MULTIPLE MYELOMA. SINGLE CENTER EXPERIENCE
    Arguinano, J. M.
    Zudaire, M.
    Pena, E.
    Aoiz, I.
    Hamdi, M.
    Mateos, M.
    Ardaiz, M.
    Viguria, M.
    Rodriguez Calvillo, M.
    Gorosquieta, A.
    Sanchez Anton, M.
    Quispe, I.
    Arregui, P.
    Montoya, M.
    Garcia Ramirez, P.
    Alvarellos, M.
    [J]. HAEMATOLOGICA, 2015, 100 : 735 - 735
  • [10] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    [J]. BLOOD, 2010, 116 (05) : 679 - 686
12345